文章基本信息

标题：Legal and regulatory update
本地全文：下载
作者：John Wilkinson
期刊名称：Journal of Commercial Biotechnology
印刷版ISSN：1478-565X
出版年度：2003
卷号：10
期号：1
DOI：10.5912/jcb59
语种：English
出版社：thinkBiotech LLC
摘要：The Office of Fair Trading (OFT) has recently found Genzyme Limited guilty of abusing its dominant position in the market for the supply of drugs for the treatment of Gaucher disease in breach of the 'Chapter II prohibition' of the Competition Act 1998. Genzyme supplies a drug called Cerezyme, which until recently was the only treatment for Gaucher disease, a rare inherited genetic disorder. Owing to the serious nature of the infringement, the OFT fined Genzyme Â£6.8m.